Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
IBS-C
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
1 other identifier
interventional
1,135
1 country
191
Brief Summary
This study in patients with IBS-C is a randomized, double-blind, placebo-controlled, parallel-group clinical trial with 12 weeks of study drug therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jun 2015
191 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 23, 2015
CompletedFirst Posted
Study publicly available on registry
July 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedResults Posted
Study results publicly available
June 14, 2019
CompletedJune 14, 2019
June 1, 2019
1.4 years
June 23, 2015
May 23, 2019
June 13, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
Number of Overall Responders - ITT Population
An Overall Responder was a patient who was a weekly responder (i.e., decrease of 30% from baseline for abdominal pain intensity and an increase of at least 1 complete spontaneous bowel movement in the same week) for at least 6 of the 12 treatment weeks.
12 weeks
Number of Abdominal Pain Responders for at Least 6 of 12 Treatment Weeks
An Abdominal Pain Intensity Responder was a patient who had a decrease of 30 % from baseline for abdominal pain intensity. Baseline is the mean of non-missing abdominal pain scores recorded during the 2-week baseline diary assessment period prior to the first dose of study drug.
12 Weeks
Number of Stool Frequency Responder for at Least 6 of the 12 Treatment Weeks
A Stool Frequency Responder was a patient who experienced an increase of at least one CSBM (complete spontaneous bowel movement) per week from baseline. Baseline was the mean number of CSBMs recorded during the 2-week baseline diary assessment period prior to the first dose of study drug.
12 Weeks
Secondary Outcomes (6)
Number of Sustained Efficacy Responders
12 Weeks
Change From Baseline in Stool Consistency
Baseline and 12-Week
Change From Baseline in Straining
Baseline and 12-Week
Change From Baseline in CSBMs (CSBMs/Week)Complete Spontaneous Bowel Movement
Baseline and 12-Week
Number of Patients With a SBM Within 24 Hours After First Dose of Study Medication
Up to 24 hours after the first dose of study drug
- +1 more secondary outcomes
Study Arms (3)
3.0 mg plecanatide
ACTIVE COMPARATORPlecanatide 3.0 mg dosed daily for 12 weeks
6.0 mg plecanatide
ACTIVE COMPARATORPlecanatide 6.0 mg dosed daily for 12 weeks
Matching placebo
ACTIVE COMPARATORPlacebo dosed daily for 12 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Adult patients between the ages of 18 and 85 years (inclusive) with a diagnosis of IBS based on ROME III diagnostic criteria and meeting criteria for diagnosis of the constipation predominant subtype - IBS-C
You may not qualify if:
- Refusal or inability to sign informed consent for the trial
- Refusal or inability to complete daily Episodic (real-time) BM / RM calls, End of Day daily Calls, and/or complete electronic questionnaires
- BMI ≥ 40 or \< 18
- Women of child bearing potential who refuse to use an acceptable method of birth control for the duration of the trial
- Women who are pregnant or lactating
- Diagnosis of IBS-D or IBS-M
- Organic or obstructive disease of the small or large intestine
- Use of laxatives other than the study-supplied rescue medication (Dulcolax®, bisacodyl)
- Use of a prohibited concomitant medication within the time frame prior to screening outlined in the study protocol for that medication
- Unstable medical illness
- Bilirubin \> 3X ULN in the absence of a conjugation defect
- Any laboratory value \> 3X ULN unless discussed and approved by the study Medical Monitor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (191)
Synergy Research Site
Birmingham, Alabama, 35209, United States
Synergy Research Site
Birmingham, Alabama, 35216, United States
Synergy Research Site
Guntersville, Alabama, 35976, United States
Synergy Research Site
Huntsville, Alabama, 35801, United States
Synergy Research Site
Saraland, Alabama, 36571, United States
Synergy Research Site
Glendale, Arizona, 85301, United States
Synergy Research Site
Phoenix, Arizona, 85018, United States
Synergy Research Site
Surprise, Arizona, 85374, United States
Synergy Research Site
Tucson, Arizona, 85745, United States
Synergy Research Site
Conway, Arkansas, 72034, United States
Synergy Research Site
Little Rock, Arkansas, 72205, United States
Synergy Research Site
Canoga Park, California, 91303, United States
Synergy Research Site
Carmichael, California, 95608, United States
Synergy Research Site
Chino, California, 91710, United States
Synergy Research Site
Chula Vista, California, 91910, United States
Synergy Research Site
El Cajon, California, 92020, United States
Synergy Research Site
Encino, California, 91436, United States
Synergy Research Site
Foothill Ranch, California, 92610, United States
Synergy Research Site
Garden Grove, California, 92844, United States
Synergy Research Site
Huntington Beach, California, 92647, United States
Synergy Research Site
Irvine, California, 92614, United States
Synergy Research Site
Lomita, California, 90717, United States
Synergy Research Site
Long Beach, California, 90806, United States
Synergy Research Site
Los Angeles, California, 90045, United States
Synergy Research Site
Mission Hills, California, 91345, United States
Synergy Research Site
Montclair, California, 91763, United States
Synergy Research Site
Northridge, California, 91324, United States
Synergy Research Site
Norwalk, California, 90650, United States
Synergy Research Site
Oceanside, California, 92056, United States
Synergy Research Site
Orange, California, 92868, United States
Synergy Research Site
Orangevale, California, 95662, United States
Synergy Research Site
Placentia, California, 92870, United States
Synergy Research Site
Riverside, California, 92501, United States
Synergy Research Site
San Diego, California, 92103, United States
Synergy Research Site
San Marino, California, 91108, United States
Synergy Research Site
Santa Ana, California, United States
Synergy Research Site
Sherman Oaks, California, 91403, United States
Synergy Research Site
Colorado Springs, Colorado, 80920, United States
Synergy Research Site
Denver, Colorado, 80246, United States
Synergy Research Site
Hamden, Connecticut, 06517, United States
Synergy Research Site
Atlantis, Florida, 33462, United States
Synergy Research Site
Boca Raton, Florida, 33428, United States
Synergy Research Site
Bradenton, Florida, 34201, United States
Synergy Research Site
Brandon, Florida, 33511, United States
Synergy Research Site
Brooksville, Florida, 34601, United States
Synergy Research Site
Clearwater, Florida, 33756, United States
Synergy Research Site
Cutler Bay, Florida, 33189, United States
Synergy Research Site
Fort Lauderdale, Florida, 33306, United States
Synergy Research Site
Fort Lauderdale, Florida, 33312, United States
Synergy Research Site
Hialeah, Florida, 33012, United States
Synergy Research Site
Hialeah, Florida, 33013, United States
Synergy Research Site
Hialeah, Florida, 33016, United States
Synergy Research Site.
Jacksonville, Florida, 32256, United States
Synergy Research Site
Lauderdale Lakes, Florida, 33319, United States
Synergy Research Site
Maitland, Florida, 32751, United States
Synergy Research Site
Miami, Florida, 33015, United States
Synergy Research Site
Miami, Florida, 33016, United States
Synergy Research Site
Miami, Florida, 33032, United States
Synergy Research Site
Miami, Florida, 33122, United States
Synergy Research Site
Miami, Florida, 33126, United States
Synergy Research Site
Miami, Florida, 33136, United States
Synergy Research Site
Miami, Florida, 33144, United States
Synergy Research Site
Miami, Florida, 33155, United States
Synergy Research Site
Miami, Florida, 33165, United States
Synergy Research Site
Miami, Florida, 33173, United States
Synergy Research Site
Miami, Florida, 33176, United States
Synergy Research Site
Miami, Florida, 33183, United States
Synergy Research Site
Miami Lakes, Florida, 33016, United States
Synergy Research Site
Miami Lakes, Florida, 33173, United States
Synergy Research Site
Miami Springs, Florida, 33166, United States
Synergy Research Site
Naples, Florida, 34102, United States
Synergy Research Site
North Miami Beach, Florida, 33162, United States
Synergy Research Site
Orange Park, Florida, 32073, United States
Synergy Research Site.
Orlando, Florida, 32806, United States
Synergy Research Site
Orlando, Florida, 32807, United States
Synergy Research Site
Ormond Beach, Florida, 32174, United States
Synergy Research Site
Pembroke Pines, Florida, 33024, United States
Synergy Research Site
Pinellas Park, Florida, 33782, United States
Synergy Research Site
Port Orange, Florida, 32127, United States
Synergy Research Site
Tamarac, Florida, 33319, United States
Synergy Research Site
Tampa, Florida, 33613, United States
Synergy Research Site
Tampa, Florida, 33634, United States
Synergy Research Site
Williston, Florida, 32696, United States
Synergy Research Site
Atlanta, Georgia, 30322, United States
Synergy Research Site
Atlanta, Georgia, 30342, United States
Synergy Research Site
Decatur, Georgia, 30033, United States
Synergy Research Site
Lilburn, Georgia, 30047, United States
Synergy Research Site
Marietta, Georgia, 30060, United States
Synergy Research Site
Snellville, Georgia, 30078, United States
Synergy Research Site
Blackfoot, Idaho, 83221, United States
Synergy Research Site
Boise, Idaho, 83709, United States
Synergy Research Site
Meridian, Idaho, 83646, United States
Synergy Research Site
Blue Island, Illinois, 60406, United States
Synergy Research Site
Chicago, Illinois, 60602, United States
Synergy Research Site
Evanston, Illinois, 60201, United States
Synergy Research Site
Hoffman Estates, Illinois, 60169, United States
Synergy Research Site
Morton, Illinois, 61550, United States
Synergy Research Site
Oak Lawn, Illinois, 60453, United States
Synergy Research Site
Schaumburg, Illinois, 60194, United States
Synergy Research Site
Brownsburg, Indiana, 46112, United States
Synergy Research Site
Indianapolis, Indiana, 46237, United States
Synergy Research Site
Wichita, Kansas, 67203, United States
Synergy Research Site
Madisonville, Kentucky, 42431, United States
Synergy Research Site
Owensboro, Kentucky, 42303, United States
Synergy Research Site
Marrero, Louisiana, 70072, United States
Synergy Research Site
Annapolis, Maryland, 21401, United States
Synergy Research Site
Catonsville, Maryland, 21228, United States
Synergy Research Site
Oxon Hill, Maryland, 20745, United States
Synergy Research Site
Towson, Maryland, 21204, United States
Synergy Research Site
Marlborough, Massachusetts, 01752, United States
Synergy Research Site
Quincy, Massachusetts, 02169, United States
Synergy Research Site
Kalamazoo, Michigan, 49009, United States
Synergy Research Site
Port Gibson, Mississippi, 39150, United States
Synergy Research Site
Chesterfield, Missouri, 63005, United States
Synergy Research Site
St Louis, Missouri, 63128, United States
Synergy Research Site
St Louis, Missouri, 63141, United States
Synergy Research Site
Missoula, Montana, 59808, United States
Synergy Research Site
Omaha, Nebraska, 68114, United States
Synergy Research Site
Las Vegas, Nevada, 89119, United States
Synergy Research Site
Blackwood, New Jersey, 08012, United States
Synergy Research Site
Egg Harbor, New Jersey, 08234, United States
Synergy Research Site
Vineland, New Jersey, 08360, United States
Synergy Research Site
Albuquerque, New Mexico, 87109, United States
Synergy Research Site
Hopewell Junction, New York, 12533, United States
Synergy Research Site
Kew Gardens, New York, 11415, United States
Synergy Research Site
New York, New York, 10016, United States
Synergy Research Site
Poughkeepsie, New York, 12601, United States
Synergy Research Site
Chapel Hill, North Carolina, 27514, United States
Synergy Research Site
Fayetteville, North Carolina, 28304, United States
Synergy Research Site
High Point, North Carolina, 27262, United States
Synergy Research Site
Jacksonville, North Carolina, 28546, United States
Synergy Research Site
Raleigh, North Carolina, 27609, United States
Synergy Research Site
Salisbury, North Carolina, 28144, United States
Synergy Research Site
Winston-Salem, North Carolina, 27103, United States
Synergy Research Site
Cincinnati, Ohio, 45224, United States
Synergy Research Site
Cincinnati, Ohio, 45242, United States
Synergy Research Site
Cincinnati, Ohio, 45249, United States
Synergy Research Site
Columbus, Ohio, 43214, United States
Synergy Research Site
Dayton, Ohio, 45419, United States
Synergy Research Site
Dayton, Ohio, 45439, United States
Synergy Research Site
Franklin, Ohio, 45005, United States
Synergy Research Site
Kettering, Ohio, 45429, United States
Synergy Research Site
Mentor, Ohio, 44060, United States
Synergy Research Site
Middleburg Heights, Ohio, 44130, United States
Synergy Research Site
Wadsworth, Ohio, 44203, United States
Synergy Research Site
Oklahoma City, Oklahoma, 73104, United States
Synergy Research Site
Doylestown, Pennsylvania, 18901, United States
Synergy Research Site
Lansdale, Pennsylvania, 19446, United States
Synergy Research Site
Levittown, Pennsylvania, 19056, United States
Synergy Research Site
Philadelphia, Pennsylvania, 19140, United States
Synergy Research Site
Anderson, South Carolina, 29621, United States
Synergy Research Site
Greer, South Carolina, 29651, United States
Synergy Research Site
Mt. Pleasant, South Carolina, 29464, United States
Synergy Research Site
Fayetteville, Tennessee, 37334, United States
Synergy Research Site
Franklin, Tennessee, 37067, United States
Synergy Research Site
Hermitage, Tennessee, 37076, United States
Synergy Research Site
Jackson, Tennessee, 38305, United States
Synergy Research Site
Kingsport, Tennessee, 37660, United States
Synergy Research Site
Knoxville, Tennessee, 37909, United States
Synergy Research Site
Austin, Texas, 78731, United States
Synergy Research Site
Austin, Texas, 78758, United States
Synergy Research Site
Baytown, Texas, 77521, United States
Synergy Research Site
Beaumont, Texas, 77701, United States
Synergy Research Site
Channelview, Texas, 77530, United States
Synergy Research Site
Dallas, Texas, 75224, United States
Synergy Research Site
Dallas, Texas, 75231, United States
Synergy Research Site
Dallas, Texas, 75254, United States
Synergy Research Site
Houston, Texas, 77008, United States
Synergy Research Site
Houston, Texas, 77081, United States
Synergy Research Site
Humble, Texas, 77338, United States
Synergy Research Site
Lampasas, Texas, 76550, United States
Synergy Research Site
McKinney, Texas, 75070, United States
Synergy Research Site
Missouri City, Texas, 77459, United States
Synergy Research Site
Plano, Texas, 75024, United States
Synergy Research Site
Plano, Texas, 75075, United States
Synergy Research Site
Port Arthur, Texas, 77640, United States
Synergy Research Site
San Antonio, Texas, 78209, United States
Synergy Research Site
San Antonio, Texas, 78215, United States
Synergy Research Site
San Antonio, Texas, 78229, United States
Synergy Research Site
Sugar Land, Texas, 77478, United States
Synergy Research Site
Orem, Utah, 84058, United States
Synergy Research Site
West Valley City, Utah, 84120, United States
Synergy Research Site
Chesapeake, Virginia, 23320, United States
Synergy Research Site
Fairfax, Virginia, 22031, United States
Synergy Research Site
Norfolk, Virginia, 23507, United States
Synergy Research Site
Richmond, Virginia, 23220, United States
Synergy Research Site
Richmond, Virginia, 23235, United States
Synergy Research Site
Spokane, Washington, 99202, United States
Synergy Research Site
Vancouver, Washington, 98664, United States
Synergy Research Site
Kingwood, West Virginia, 26537, United States
Synergy Research Site
La Crosse, Wisconsin, 54601, United States
Related Publications (3)
Brenner DM, Shin AS, Laitman AP, Deutsch JK, Kunkel DC. The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint. J Gastroenterol Hepatol. 2025 Dec;40(12):2890-2897. doi: 10.1111/jgh.70119. Epub 2025 Nov 10.
PMID: 41214272DERIVEDCash BD, Sharma A, Walker A, Laitman AP, Chang L. Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation. Neurogastroenterol Motil. 2023 Sep;35(9):e14632. doi: 10.1111/nmo.14632. Epub 2023 Jun 18.
PMID: 37332239DERIVEDMenees SB, Franklin H, Chey WD. Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older. Clin Ther. 2020 Jul;42(7):1406-1414.e4. doi: 10.1016/j.clinthera.2020.05.012. Epub 2020 Jul 10.
PMID: 32660770DERIVED
MeSH Terms
Interventions
Results Point of Contact
- Title
- VP Regulatory Affairs & Clinical QA
- Organization
- Synergy Pharmaceuticals Inc.
Study Officials
- STUDY DIRECTOR
Paul F.C. Eng, PhD
Synergy Pharmaceuticals Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2015
First Posted
July 9, 2015
Study Start
June 1, 2015
Primary Completion
November 1, 2016
Study Completion
February 1, 2017
Last Updated
June 14, 2019
Results First Posted
June 14, 2019
Record last verified: 2019-06